Related Experiment Video
Updated: Aug 15, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Netilmicin in the treatment of neonates with moderate and severe infections
Abstract:
Thirty neonates and infants have been treated for verified or suspected infections with a combination of netilmicin and ampicillin intravenously for 7 days. The infecting organisms were isolated in 18 patients, of whom 2 had osteomyelitis and 2 had pneumonia. In 3 cases of pneumonia and 9 cases of suspected septicaemia bacteriological cultures were negative. None of the children died, and in all but the 2 cases of osteomyelitis, therapy led to complete resolution of the signs of infection and recovery without sequelae. No adverse reactions to antibiotic therapy were recorded. Upon follow-up examinations at the age of 3 months there has been no sign of auditory impairment as assessed by Brain Stem Evoked Response. Netilmicin is thus tolerated well in neonates and infants, and when guided by serum concentrations considered to be a safe and reliable aminoglycoside.
Insights
This study found that combining netilmicin and ampicillin for 7 days effectively treated infections in neonates and infants. The antibiotic combination showed good tolerance and no adverse effects, including no auditory impairment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Neonates and infants are susceptible to serious bacterial infections.
- Empirical antibiotic therapy is often necessary in this population.
- Netilmicin, an aminoglycoside, requires careful dosing and monitoring in pediatric patients.
Purpose of the Study:
- To evaluate the efficacy and safety of intravenous netilmicin and ampicillin combination therapy in neonates and infants.
- To assess the incidence of adverse reactions and long-term sequelae, including auditory impairment.
Main Methods:
- A prospective study involving 30 neonates and infants treated for verified or suspected infections.
- Intravenous administration of netilmicin and ampicillin for 7 days.
- Monitoring of clinical outcomes, bacteriological cultures, and auditory function via Brain Stem Evoked Response at 3 months.
Main Results:
- Complete resolution of infection signs and recovery without sequelae in most patients (28/30).
- Two cases of osteomyelitis showed incomplete resolution.
- No deaths or adverse reactions to the antibiotic therapy were recorded.
- No auditory impairment was detected at 3-month follow-up.
Conclusions:
- The combination of netilmicin and ampicillin is safe and effective for treating infections in neonates and infants.
- Netilmicin, when guided by serum concentrations, is a reliable aminoglycoside for this age group.
- Further studies may be warranted to confirm findings in specific infections like osteomyelitis.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Microbiota Modulation by Antibiotics
Anthelminthic Agents
Bacterial Meningitis I: Introduction

